Zobrazeno 1 - 10
of 336
pro vyhledávání: '"Shigetoyo Saji"'
Autor:
Masashi Kanai, Takahisa Kawaguchi, Masahito Kotaka, Dai Manaka, Junichi Hasegawa, Akinori Takagane, Yoshinori Munemoto, Takeshi Kato, Tetsuya Eto, Tetsuo Touyama, Takanori Matsui, Katsunori Shinozaki, Shigemi Matsumoto, Tsunekazu Mizushima, Masaki Mori, Junichi Sakamoto, Atsushi Ohtsu, Takayuki Yoshino, Shigetoyo Saji, Fumihiko Matsuda
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 7808-7814 (2023)
Abstract Objective Dihydropyrimidine dehydrogenase (DPYD) genotype is closely associated with fluoropyrimidine (FP)‐induced toxicities in Caucasian population and European Medicines Agency now recommends DPYD genotype‐based FP dosing strategy. Pa
Externí odkaz:
https://doaj.org/article/22d0decfa3754b00b4a85b0440d3496a
Autor:
Masashi Kanai, Takahisa Kawaguchi, Masahito Kotaka, Dai Manaka, Junichi Hasegawa, Akinori Takagane, Yoshinori Munemoto, Takeshi Kato, Tetsuya Eto, Tetsuo Touyama, Takanori Matsui, Katsunori Shinozaki, Shigemi Matsumoto, Tsunekazu Mizushima, Masaki Mori, Junichi Sakamoto, Atsushi Ohtsu, Takayuki Yoshino, Shigetoyo Saji, Fumihiko Matsuda
Publikováno v:
Cancer medicineREFERENCES.
Dihydropyrimidine dehydrogenase (DPYD) genotype is closely associated with fluoropyrimidine (FP)-induced toxicities in Caucasian population and European Medicines Agency now recommends DPYD genotype-based FP dosing strategy.The current study aimed to
Autor:
Junichi Sakamoto, Naohiro Tomita, Chikuma Hamada, Shigeki Yamaguchi, Atsuyuki Maeda, Katsuyuki Kunieda, Takeharu Yamanaka, Toshihiko Sato, Sotaro Sadahiro, Narikazu Boku, Kazuhiro Yoshida, Shigetoyo Saji, Megumi Ishiguro, Kei Muro, Riichiro Nezu, Hideyuki Mishima, Yoshihiko Maehara
Publikováno v:
British Journal of Cancer
Background Up to 6-months oxaliplatin-containing regimen is now widely accepted as a standard adjuvant chemotherapy for stage III colorectal cancer (CRC). However, oral fluoropyrimidine monotherapy is used for some part of patients, especially in Asi
Autor:
Mitsuo Shimada, Masaaki Nishi, Koutarou Maeda, Takashi Kanematsu, Hiroki Sokuoka, Shigetoyo Saji, Kozo Yoshikawa, Yuji Morine, Keisuke Koeda, Mitsuo Kusano, Hidetoshi Katsuno, Yasuto Sato, Yoshihiko Maehara, Masahiko Watanabe, Masaki Kitajima, Satoshi Morita, Toru Kono, Junichi Sakamoto
Publikováno v:
Surgery Today
Purpose Prolonged postoperative ileus (POI) is a common complication after open abdominal surgery (OAS). Daikenchuto (DKT), a traditional Japanese medicine that peripherally stimulates the neurogenic pathway, is used to treat prolonged POI in Japan.
Autor:
K Kaneko, Nayuko Sato, Noriyuki Masuda, Chizuko Kanbayashi, M. Toi, Hiroyuki Yasojima, Shigetoyo Saji, Takashi Morimoto, Taro Ueno, Shinji Ohno, Hironobu Sasano, Satoshi Morita
Publikováno v:
Cancer Research. 79:P4-14
Aim To investigate the efficacy and safety of initial neoadjuvant endocrine therapy with exemestane (EXE) alone followed by tailored treatment: continued EXE monotherapy for responders or EXE plus docetaxel–cyclophosphamide (TC) combination therapy
Autor:
Tetsuo Touyama, Tetsuya Eto, Takanori Matsui, T. Mizushima, Takayuki Yoshino, Junichi Hasegawa, Y. Munemoto, Masahito Kotaka, K. Shinozaki, A. Ohtsu, Junichi Sakamoto, Masaki Mori, Dai Manaka, T. Kato, Takahisa Kawaguchi, Akinori Takagane, Masashi Kanai, S. Matsumoto, Shigetoyo Saji, Fumihiko Matsuda
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 32(11)
[Background] The severity of oxaliplatin (L-OHP)-induced peripheral sensory neuropathy (PSN) exhibits substantial interpatient variability, and some patients suffer from long-term, persisting PSN. To identify single-nucleotide polymorphisms (SNPs) pr
Autor:
Takayuki Kadoya, Kosuke Kawaguchi, Hiroko Bando, Noriyuki Masuda, M. Toi, Shigetoyo Saji, R. Velaga, Hironori Haga, Tomio Nakayama, M. Yamashita, Shoichiro Ohtani, Shuko Morita, Takeharu Yamanaka, Masazumi Takahashi, Shinji Ohno, S. Nagai, K. Aogi, Takayuki Ueno, Shigehisa Kitano, D. Ikarashi
Publikováno v:
Annals of Oncology. 32:S1217-S1218
Autor:
Masahito Shimizu, Kosuke Hasegawa, Atsushi Suetsugu, Hisataka Moriwaki, Shigetoyo Saji, Robert M. Hoffman, Miki Nakamura, Tomoyuki Satake, Takahiro Kunisada
Publikováno v:
Anticancer Research. 38:4417-4423
Background/aim Our laboratory pioneered color-coded imaging of the tumor microenvironment (TME). We observed recruitment of cancer and stromal cells to the TME and recombination between cancer and stromal cells. The aim of the present study was to ob
Autor:
Hiromichi Maeda, Takaki Yoshikawa, Kosuke Kashiwabara, Shuhei Mayanagi, Koji Oba, Junichi Sakamoto, Toru Aoyama, Mitsuro Kanda, Sotaro Sadahiro, Michitaka Honda, Shigetoyo Saji, Chikuma Hamada
Publikováno v:
Diseases of the Colon and Rectum
BACKGROUND: Most previous reports to analyze risk factors for peritoneal recurrence in patients with colon cancer have been observational studies of a population-based cohort. OBJECTIVE: This study aimed to determine the risk factors for peritoneal r
Autor:
Hiroyuki Yasojima, Chizuko Kanbayashi, Shigetoyo Saji, Nayuko Sato, Taro Ueno, Noriyuki Masuda, Shinji Ohno, K Kaneko, Hironobu Sasano, M. Toi, Takashi Morimoto, Satoshi Morita
Publikováno v:
Cancer Research. 78:P3-13
Aims We investigated the efficacy and safety of initial neoadjuvant endocrine therapy with exemestane (EXE) alone followed by subsequent tailored treatment with EXE alone for responders or EXE plus oral metronomic cyclophosphamide (CPA) for non-respo